Showing results (1981-1990 of 2,375) with videos related to

Sort By:
Pageof 238
JBMR Plus|October 9, 2023
Modest Effects of Osteoclast-Specific ERα Deletion after Skeletal MaturityMadison L Doolittle, Brittany A Eckhardt, Stephanie J Vos, et al.
JCI Insight|January 9, 2025
A PAS-targeting hERG1 activator reduces arrhythmic events in Jervell and Lange-Nielsen syndrome patient-derived hiPSC-CMsChiamaka U Ukachukwu, Eric N Jimenez-Vazquez, Shreya Salwi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancerGhassan K Abou-Alfa, Richard Letourneau, Graydon Harker, et al.
Beilstein Journal of Organic Chemistry|June 7, 2021
Structural effects of meso-halogenation on porphyrinsKeith J Flanagan, Maximilian Paradiz Dominguez, Zoi Melissari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory propertiesA W Tolcher, S G Eckhardt, J Kuhn, et al.
The Journal of Biological Chemistry|February 24, 2006
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activationDiane Gesty-Palmer, Minyong Chen, Eric Reiter, et al.
Preventive Medicine|July 1, 1997
Reducing ultraviolet radiation exposure in childrenJ A Mayer, D J Slymen, L Eckhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignanciesD Ross Camidge, Roy S Herbst, Michael S Gordon, et al.
Cephalalgia : an International Journal of Headache|January 9, 2023
Effects of acupuncture and medical training therapy on depression, anxiety, and quality of life in patients with frequent tension-type headache: A randomized controlled studyJoerg Schiller, Daniel Niederer, Tim Kellner, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2005
Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr)Sridharan Rajamani, Corey L Anderson, Carmen R Valdivia, et al.
Pageof 238